Since most TLR-4 mediated inflammatory responses are initiated by recruiting MyD88, a key intracellular adaptor protein of TLR-4 [17], TLR-4/MyD88 dependent pathway is a potential target for curing the AD progress induced by LPS-mediated neuroinflammation. This evidence concerns the gene TLR4 and Alzheimer disease.